BackXenon Pharmaceuticals Overview
Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Target Price

Where could XENE trade next? Consensus target price: $70.

Get informed when a big investor buys or sells

+ Follow

Share Price

$40.48

Average Target Price

$70.0072.9% upside

9 analysts in the last 4 months

High: $90 | Low: $46

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-28JefferiesAndrew Tsai$90122.3% upsideOpen
2026-09-18RBC Capital$7072.9% upsideOpen
2026-09-18Wedbush$5535.9% upsideOpen
2026-09-18Needham$6048.2% upsideOpen
2026-09-18Robert W. Baird$90122.3% upsideOpen
2026-09-18Wells FargoBenjamin Burnett$6458.1% upsideOpen
2026-09-18Deutsche BankDavid Hoang$4613.6% upsideOpen
2026-08-10H.C. WainwrightDouglas Tsao$7482.8% upsideOpen
2026-08-07RBC CapitalBrian Abrahams$81100.1% upsideOpen
2026-05-10Wells FargoBenjamin Burnett$6970.5% upsideOpen
2026-05-08NeedhamSerge Belanger$7892.7% upsideOpen
2026-03-10Deutsche Bank$90122.3% upsideOpen
2026-03-09RBC Capital$8097.6% upsideOpen
2026-03-09JefferiesAndrew Tsai$100147% upsideOpen
2026-03-09GuggenheimYatin Suneja$90122.3% upsideOpen
2026-03-09Morgan Stanley$97139.6% upsideOpen
2026-03-09Robert W. Baird$97139.6% upsideOpen
2026-03-09Stifel NicolausPaul Matteis$89119.9% upsideOpen
2026-03-09JefferiesAndrew Tsai$6560.6% upsideOpen
2026-02-23Wolfe Research$6048.2% upsideOpen
2026-02-10Stifel Nicolaus$6663% upsideOpen
2025-11-04RBC Capital$5843.3% upsideOpen
2025-11-04Cantor FitzgeraldJosh Schimmer$5535.9% upsideOpen
2025-11-04Wells FargoBenjamin Burnett$448.7% upsideOpen
2025-02-28Wedbush$423.8% upsideOpen
2024-10-10Raymond JamesDanielle Brill$5023.5% upsideOpen
2024-10-01H.C. WainwrightDouglas Tsao$5330.9% upsideOpen
2024-08-09WedbushLaura Chico$4921% upsideOpen
2024-06-18RBC CapitalBrian Abrahams$5535.9% upsideOpen
2022-12-14Goldman Sachs$6048.2% upsideOpen
2022-11-28Wells Fargo$5023.5% upsideOpen
2022-11-11Guggenheim$4921% upsideOpen
2022-10-18Raymond JamesDanielle Brill$5228.5% upsideOpen
2022-08-11Leerink Partners$4613.6% upsideOpen
2022-08-10RBC Capital$4613.6% upsideOpen
2022-06-27Wedbush$411.3% upsideOpen
2022-05-11RBC Capital$411.3% upsideOpen

Xenon Pharmaceuticals (XENE) FAQ

Xenon Pharmaceuticals's target price stands at $70. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $70 for XENE implies 72.9% upside versus today's price ($40.48). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Xenon Pharmaceuticals's target price evolved across reporting periods, while the comparison chart places XENE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Xenon Pharmaceuticals's reading of $70 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.